News & Analysis as of

Pediatrics

Stark & Stark

What Every Parent Should Know About Childhood Concussions and Long-Term Learning

Stark & Stark on

We all know that childhood is full of bumps, bruises, and yes—sometimes concussions. A tumble off a bike, a collision on the soccer field—it happens. But what if those head injuries, even the “mild” ones, could echo into your...more

Womble Bond Dickinson

Unlocking the Secrets of the Endocannabinoid System: A New Frontier in Therapeutic Cannabis Research for Adolescents

Womble Bond Dickinson on

Humans possess several well-established bodily systems, including the sympathetic nervous system, the central nervous system, and the endocrine system. A relatively recent discovery is the endocannabinoid system (ECS)....more

Hogan Lovells

FDA announces public meeting on pediatric exclusivity and drug development

Hogan Lovells on

Earlier this month, the U.S. Food and Drug Administration (FDA) announced a public meeting entitled “Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act”...more

Morris James LLP

Child and Pediatric Medical Malpractice FAQs

Morris James LLP on

When a child suffers harm due to medical negligence, the emotional toll on families can be overwhelming. Parents trust healthcare providers to deliver care that protects and nurtures their child’s well-being. When they make...more

Hogan Lovells

Rare pediatric disease Priority Review Voucher program renewed through Dec. 20

Hogan Lovells on

U.S. President Biden signed a bill last Thursday postponing the sunset date of the rare pediatric disease Priority Review Voucher (PRV) program from September 30, 2024, to December 20, 2024. The bill, the “Continuing...more

Goodwin

A Look Ahead in Life Sciences: What We Are Tracking in the Fourth Quarter of 2024 and Beyond

Goodwin on

As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape....more

ArentFox Schiff

The Accelerating Kids’ Access to Care Act: Breaking Barriers for Pediatric Patients Across State Lines

ArentFox Schiff on

In July 2023, US Senators Michael Bennet (D-CO) and Chuck Grassley (R-IA), along with US Representatives Lori Trahan (D-MA) and Mariannette Miller-Meeks (R-IA), introduced legislation to improve access to critical care for...more

Goodwin

A Look Ahead in Life Sciences: What We Are Tracking in the Third Quarter of 2024 and Beyond

Goodwin on

As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape. ...more

Sheppard Mullin Richter & Hampton LLP

Gamification – Playing for Health: A Discussion with Craig Lund

In the rapidly evolving landscape of digital health, gamification has emerged as a powerful tool to enhance patient engagement and improve health outcomes. In the fifth episode of Sheppard Mullin’s Health-e Law Podcast, Craig...more

Holland & Knight LLP

Holland & Knight Health Dose: March 5, 2024

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Benesch

2024 Outlook: Behavioral Health Trends

Benesch on

Healthcare systems are facing significant challenges in recruiting and retaining talent within the burgeoning field of behavioral health services, primarily due to competition from telehealth providers and inconsistent...more

Foley & Lardner LLP

A Look at FDA’s Proposed Changes to Labeling for Biosimilars and Interchangeable Biosimilars

Foley & Lardner LLP on

The labeling of biosimilar products as “interchangeable” may be important in order to gain acceptance and use in the medical community. This article provides important information regarding revised FDA labeling guidance for...more

Hogan Lovells

New FDA pediatric draft guidances include proposal that could limit pediatric exclusivity grants

Hogan Lovells on

The U.S. Food and Drug Administration (FDA) has issued two new draft guidance documents on pediatric drug development and exclusivity, most notably clarifying that, under a new proposed policy that would come into play upon...more

Stevens & Lee

Expanding Support for Pediatric Mental Health Care

Stevens & Lee on

Since the onset of the COVID-19 pandemic, children have experienced an unprecedented mental health crisis. In response, President Biden has prioritized strengthening and expanding the Pediatric Mental Health Care Access...more

Patrick Malone & Associates P.C. | DC Injury...

More shots coming to battle stubborn, still deadly coronavirus pandemic

The coronavirus pandemic stubbornly persists, infecting 110,000 Americans daily - and likely many, many more - and hospitalizing 29,000 a day on average. Vaccinations, also, have stayed at the forefront of efforts to...more

Patrick Malone & Associates P.C. | DC Injury...

As pediatricians seek to end race bias in care, a caution on parent burnout

While the nation’s pediatricians have announced an important, high-minded goal of eliminating racial bias in the medical treatment of children, working parents and other full-time caregivers for kids need a different kind of...more

Stark & Stark

Persistent Post Concussive Syndrome in Children After Mild Traumatic Brain Injury

Stark & Stark on

In defending pediatric traumatic brain injury cases, defense experts often allege that the pediatric TBI survivor did not sustain any permanent injuries based on the antiquated philosophy that due to neuroplasticity...more

Fox Rothschild LLP

Vaccine Wars Round 2: Are These Claims Justiciable?

Fox Rothschild LLP on

In October there was a local case where parents were in conflict over vaccination of an incapacitated adult child. In that case, Matter of A.C.G., after an evidentiary hearing, the Court ruled that the child could be...more

Health Care Compliance Association (HCCA)

Fake Histories, Calls by Staff Impersonating Subjects: A Look Inside Two Trial Fraud Cases

Report on Research Compliance 19, no. 2 (January 27, 2022) - The trial was to be like any other that the clinical research organization (CRO) would oversee. The six-month study, known as VESTRI, would involve pediatric...more

Bricker Graydon LLP

COVID-19 vaccines now available for most children and all teens

Bricker Graydon LLP on

The Pfizer-BioNTech COVID-19 vaccine has been authorized by the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) for administration to children aged 5-11 years old. ...more

Cozen O'Connor

1st Amendment Win For Credit Card Surcharges| Texas Sues Over Electricity Bills | Dodgy COVID Fees

Cozen O'Connor on

2022 AG Elections- Former South Dakota Attorney General Steps Back into Contention for AG’s Office- •Marty Jackley, who formerly served as U.S. Attorney for South Dakota, South Dakota AG, and President of the National...more

Health Care Compliance Association (HCCA)

Florida medical doctor pleads guilty to conspiring to falsify clinical trial data

Compliance Today (March 2021) - According to a recent U.S. Department of Justice news release, Yvelice Villaman Bencosme, a Miami, Florida, doctor and the primary investigator for clinical trials designed to investigate...more

MoFo Life Sciences

Rare Disease: Sustained Progress In Development Regardless Of The Pandemic

MoFo Life Sciences on

Sunday, February 28, 2021, was Rare Disease Day. With so much focus on COVID-19 throughout 2020, it’s important to recognize the continued work done in rare disease drug development by sponsors and FDA throughout 2020. In...more

Bricker Graydon LLP

Florida pediatrician pleads guilty to conspiring to falsify clinical trial data in research study for asthma medication for...

Bricker Graydon LLP on

On January 8, 2021, the Department of Justice announced that a Miami, Florida pediatrician pleaded guilty to one count of wire fraud in connection with a clinical research study of an asthma medication for children. ...more

Health Care Compliance Association (HCCA)

Report on Research Compliance Volume 17, Number 12. In This Month's E-News: December 2020

Report on Research Compliance 17, no. 12 (December 2020) - Finalizing a document issued last year, on Nov. 9 the Food and Drug Administration issued “Enhancing the Diversity of Clinical Trial Populations—Eligibility...more

45 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide